Source: Filippatos G, et al. Late Breaking Clinical Trials V. Presented at: American College of Cardiology Scientific Session; May 15-17, 2021 (virtual meeting).
Bayer AG funded FIDELIO-DKD and analyses were conducted by the sponsor. Filippatos reports he received lectures fees or is a committee member of trials and registries sponsored by Amgen, Bayer, Boehringer Ingelheim, Medtronic, Novartis, Servier and Vifor Pharma. He is a senior consulting editor for JACC:…